In 2005, American psychiatrist and bioengineer Karl Deisseroth demonstrated that channelrhodopsin-2 (ChR2) could act as an optical switch in mammalian neurons. The neurons, genetically engineered to express ChR2 on their surface, could be turned on when exposed to a flash of blue light, enabling very rapid and precise control over neuron activation without compromising cell structure.
verifiedCite
While every effort has been made to follow citation style rules, there may be some discrepancies.
Please refer to the appropriate style manual or other sources if you have any questions.
Select Citation Style